Amdocs (NASDAQ:DOX) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Amdocs (NASDAQ:DOXGet Free Report) issued its earnings results on Wednesday. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01, FiscalAI reports. The firm had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.78 earnings per share. Amdocs updated its FY 2026 guidance to 7.340-7.480 EPS and its Q3 2026 guidance to 1.810-1.870 EPS.

Here are the key takeaways from Amdocs’ conference call:

  • Amdocs reported a solid Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both above the midpoint of guidance, with year-over-year growth in North America and record revenue in Europe.
  • The company secured several meaningful contract wins and extensions, including expanded managed services with Cricket Wireless, a 5-year CRM/OSS modernization deal with Vodafone Spain, and a multi-year charging system extension with KT.
  • Amdocs said its new aOS agentic operating system is getting early traction, with initial commercial agreements from Cricket, Lumen, Bell Canada, EchoStar, and PLDT; PLDT is already seeing over 90% of customer requests resolved through the platform.
  • Management reiterated full-year fiscal 2026 guidance, including 3% constant-currency revenue growth at the midpoint and roughly 6% non-GAAP EPS growth, while noting it is still monitoring customer spending amid macro uncertainty.
  • Cash generation remained strong, with $97 million in free cash flow before restructuring in Q2 and the company on track for $710 million to $730 million for fiscal 2026, supporting continued shareholder returns and liquidity.

Amdocs Stock Performance

NASDAQ DOX traded down $2.41 during trading hours on Wednesday, hitting $59.93. The company had a trading volume of 1,810,046 shares, compared to its average volume of 953,890. The business has a 50 day moving average of $65.54 and a 200-day moving average of $73.80. The company has a market cap of $6.47 billion, a PE ratio of 11.59, a price-to-earnings-growth ratio of 1.10 and a beta of 0.40. Amdocs has a 1-year low of $59.40 and a 1-year high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06.

Institutional Trading of Amdocs

Several institutional investors and hedge funds have recently made changes to their positions in the company. EP Wealth Advisors LLC acquired a new stake in shares of Amdocs in the 4th quarter valued at about $631,000. Mackenzie Financial Corp increased its position in Amdocs by 218.0% during the fourth quarter. Mackenzie Financial Corp now owns 118,898 shares of the technology company’s stock worth $9,644,000 after buying an additional 81,504 shares during the period. NewEdge Advisors LLC lifted its stake in Amdocs by 8.6% in the fourth quarter. NewEdge Advisors LLC now owns 11,276 shares of the technology company’s stock valued at $908,000 after buying an additional 897 shares during the last quarter. Empowered Funds LLC lifted its stake in Amdocs by 97.4% in the fourth quarter. Empowered Funds LLC now owns 41,466 shares of the technology company’s stock valued at $3,338,000 after buying an additional 20,460 shares during the last quarter. Finally, XTX Topco Ltd boosted its holdings in shares of Amdocs by 41.2% in the fourth quarter. XTX Topco Ltd now owns 14,183 shares of the technology company’s stock valued at $1,142,000 after acquiring an additional 4,139 shares during the period. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs News Summary

Here are the key news stories impacting Amdocs this week:

Wall Street Analyst Weigh In

DOX has been the subject of several analyst reports. Stifel Nicolaus lowered their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, April 18th. Barclays decreased their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.33.

View Our Latest Report on Amdocs

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Featured Stories

Earnings History for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.